Polishing Complex Therapeutic Proteins - A new downstream purification platform using a salt-tolerant membrane adsorber. - BioPharm International

ADVERTISEMENT

Polishing Complex Therapeutic Proteins
A new downstream purification platform using a salt-tolerant membrane adsorber.


BioPharm International
Volume 26, Issue 1, pp. 42-51

REFERENCES

1. S. Brandt et al., Nat. Biotechnol. 6, 779–782 (1988).

2. J. Thommes and M.R. Kula, Biotechnol. Progress 11, 357–367 (1995).

3. R. Ghosh, J. Chromatogr. A 952, 13–27 (2002).

4. J.H. Vogel et al., Biotechnol. Bioeng. 109 (12) 3049–3058 (2012).

5. H.L. Knudsen et al., J. Chromatogr. A 907, 145–154 (2001).

6. M. Phillips et al., J. Chromatogr. A 1078, 74–82 (2005).

7. J.X. Zhou and T. Tressel, Biotechnol. Progress 22, 341–349 (2006).

8. N. Fraud, Bioprocessing J. 7 (2), 26–29 (2008).

9. A. Arunakumari, J. Wang, and G. Ferreira, "New Standards in Virus and Contaminant Removal" supplement to BioPharm Int. 20, s6–s10 (2007).

10. A. Clutterbuck, J. Kenworthy, and J. Liddell J, "New Standards in Virus and Contaminant Removal" supplement to BioPharm Int. 20, s11–s14 (2007).

11. D. Farb, presentation at Downstream Technology Forum (King of Prussia, Pennsylvania, 2006).

12. M. Kuczewski et al., Biotechnol. Bioeng. 105 (2), 296–305 (2010).

13. J.X. Zhou et al., J. Chromatogr. A 1134, 66–73 (2006).

14. N. Fraud et al., BioPharm Int. 23 (8), 44–52 (2010).

15. J.A.C. Lim et al., BioProcess Int. 5, 60–64 (2007).

16. W. Riordan et al., Biotechnol. Bioeng. 103 (5), 920–929 (2009)

17. R. Faber, Y. Yang, and U. Gottschalk,, Supplement to BioPharm Int. 22, 11-14 (2009).

18. I. Tatarova et al., J. Chromatogr. A 1216, 941–947 (2009).

19. J.X. Zhou et al., Biotechnol. Bioeng. 100 (3), 488–496 (2008).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here